In PyMT mice, SAHA delays tumor growth and reduces tumor burden and inhibits TAM infiltration of estrogen receptor-negative (ER-) mammary tumors while decreasing M-CSF and MMP-9 levels in these tumors [90]. Here, CSF1 is linked to neoplasm.